Xcout Intel
Biorce competitors & alternatives
The 12 closest competitors and alternatives to Biorce among biotech companies — ranked by similarity to what Biorce actually does, not by market-cap band.
Subscribe to see Biorce’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Biorce
Biorce is a biotechnology research company headquartered in Barcelona, Spain, with a team of around 180 employees. The company develops artificial intelligence platforms and operating systems designed to automate and streamline clinical trials with built-in review processes and human oversight.
Biorce at a glance
Biorce is a biotech company headquartered in Spain. It has raised at least $56.3M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $52.5M in February 2026. Xcout tracks 2 named people at Biorce, including Pedro Coelho (CEO).
Biorce leadership
- Pedro CoelhoCEO
- Pedro CoelhoFounder
Biorce funding rounds
At least $56.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $52.5M | 7 named | |
| Series A | $3.8M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Biorce competitors
Ranked by semantic similarity — how close each company is to Biorce by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Biotechnology
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Healthcare
Aira Health is a biotechnology research company based in Boston, Massachusetts, that provides a unified AI platform for clinical trial design and protocol development.
Healthtech
ArcaScience is a pharmaceutical artificial intelligence company headquartered in Paris, France, that develops an advanced benefit-risk decision engine and drug safety platforms.
Similar biotech company
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Life Sciences
Ryght AI is an artificial intelligence company headquartered in Southern California that provides an AI-powered platform to rapidly analyze clinical trial protocols and connect researchers with sites worldwide.
Similar biotech company
BenevolentAI provides an artificial intelligence platform and life science intelligence tools designed to assist scientists and pharmaceutical executives in drug discovery and research and development decision-making. The company leverages proprietary technology and machine learning to analyze biological data and support complex R&D processes.
Similar biotech company
Formation Bio is a U.S.-based technology and drug-development company, formerly known as TrialSpark, that uses AI and software to help pharmaceutical companies develop medicines more efficiently. It serves biopharmaceutical partners by supporting clinical-trial operations and other parts of the drug-development process.
Similar biotech company
VeriSIM Life provides an AI-driven drug discovery and development platform called BIOiSIM that uses mechanistic and quantitative methods to predict patient outcomes and de-risk clinical trials. The company serves pharmaceutical companies, biotechnology firms, and academic research institutions by generating actionable insights for drug repurposing, safety-toxicity profiles, and efficacy predictions.
Biotechnology
MDVerse Inc. provides a software, analytics, and generative AI platform designed to support the advanced therapy medicinal products (ATMP) ecosystem. The company integrates drug creators, pharmaceutical companies, contract manufacturers, and clinical sites to streamline the supply chain, manufacturing, and delivery of precision cell and gene therapies.
Similar biotech company
Cradle is a private biotechnology company founded in 2021, specializing in artificial intelligence. The company operates its own wet lab in Amsterdam to develop reliable and high-performing models.
Similar biotech company
Antiverse is a biotechnology research company headquartered in Cardiff, Wales, that utilizes generative artificial intelligence to design functional antibodies for challenging drug targets.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Biorce and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Biorceand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →